Migraine Disorders: Clinical Trials

165 trials for Migraine Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

103 completed, 19 unknown, 14 terminated, 11 recruiting. 165 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 4165Completed 103, Unknown 19, Terminated 14, Recruiting 11, Not yet recruiting 7, Withdrawn 6, Active not recruiting 3, Enrolling by invitation 1, Suspended 1

Follow Migraine Disorders: new trials by email Literature Review of Migraine Disorders trials Research Report on Migraine Disorders

Trials (filtered) newest first · largest first

All 165 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Calcitonin Gene-related Peptide Antibody in Acute Mountain Sickness
Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution, Placebo - Acute Mountain Sickness
Phase 4Not yet recruitingInsel Gruppe AG, University Hospital Bern302027-06-012026-07-01
Nortriptyline Compared With Amitriptyline for Migraine Prevention at SQUH
Nortriptyline, Amitriptyline - Migraine
Phase 4Not yet recruitingSultan Qaboos University902027-05-012026-10-02
Migraine Menopause Study
Eptinezumab 100 mg or Eptinezumab 300 mg administered intravenously in 100 mL saline solution, Placebo Normal Saline (NS) - Migraine, Menopausal
Phase 4Not yet recruitingAlberta Neurologic Centre1202027-02-012026-11-04
Effect of Atogepant on the Vestibulo-Ocular Reflex in Healthy Adults and Adults With Migraine
Atogepant 60 mg, Placebo - Migraine Disorders, Brain, Healthy Adult Participants
Phase 4Not yet recruitingKonrad Peter Weber802027-01-012026-09-17
A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
Rimegepant 75 mg ODT - Acute Treatment of Migraine
Phase 4RecruitingPfizer602026-07-242026-10-15
Comparing Migraine Preventive Therapies vs. Anti-CGRP Therapies for Tinnitus in Patients With Migraine (COMPACT-PM)
Galcanezumab, Erenumab 70 mg, Eptinezumab - Migraine Associated Vertigo, Tinnitus
Phase 4Not yet recruitingStanford University1202026-07-012026-06-17
Treatment Patterns Among US Veterans Using Remote Electrical Neuromodulation (REN) for Migraine Treatment
Nerivio REN device - Migraine, Acute Treatment of Migraine
Phase 4CompletedTheranica4662026-01-092026-04-03
Nerivio Efficacy Under High-Frequency Use
Nerivio (REN device) - Migraine
Phase 4Active not recruitingTheranica20002026-01-082026-01-13
Evaluation of MIG-SPRAY Treatment on Migraine
MIG-SPRAY - Migraine
Phase 4Active not recruitingUniversity Hospital, Clermont-Ferrand452025-09-152026-03-18
Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US
Rimegepant 75 MG - Migraine, Trigger Induced Migraine
Phase 4RecruitingMedstar Health Research Institute602025-09-092025-12-24
Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks
Canvert-M (Produced by Alasht Pharmed co. Iran) - Migraine Disorders
Phase 4RecruitingAlasht Pharmed302025-07-162025-07-30
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
Atogepant 60 mg, Propranolol 160 mg, Topiramate 100 mg - Migraine
Phase 4RecruitingMayo Clinic13352025-07-092026-11-13
Acute Migraine Treatment in the ED With Gepants
Rimegepant, Zavegepant - Migraine Headaches
Phase 4TerminatedIcahn School of Medicine at Mount Sinai92025-06-052026-04-29
Management of Acute Tinnitus With Migraine Medications
Nortriptyline, Topiramate, Paroxetine - Tinnitus
Phase 4SuspendedUniversity of California, Irvine1002025-06-012026-10-27
Nerivio Efficacy by Time of Treatment Onset
Nerivio - Migraine, Acute Treatment of Migraine
Phase 4CompletedTheranica552612025-05-072025-07-31
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
Eptinezumab - Migraine
Phase 4CompletedH. Lundbeck A/S1642024-12-182026-09-09
Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care
Topiramate, Flunarizine, Amitriptyline - Migraine
Phase 4Not yet recruitingFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina4602024-10-012024-07-12
A Comparison of Nurtec ODT to Maxalt MLT-ODT in Adult ED Patients With Migraine Headache
Rimegepant, Rizatriptan Benzoate - Migraine
Phase 4RecruitingAntonios Likourezos802024-09-012026-09-24
Impact of Combined Oral Contraceptive Pills on Migraine
Combined oral contraceptive, Vaginal Ring - Migraine
Phase 4RecruitingKafrelsheikh University4002024-07-152024-10-09
Role of Ultrasound Guide Greater Occipital Nerve Block at Second Cervical Vertebra in Migraine Headache Prophylaxis
Placebo, Bupivacaine - Migraine Disorders
Phase 4Not yet recruitingMahidol University1082024-05-302024-05-29

Showing 20 of 165. Sign in to see all of them.

Narrower conditions

Headache (31)  ·  Migraine with Aura (10)  ·  Migraine without Aura (10)  ·  Emergencies (8)  ·  Pain (4)  ·  Headache Disorders (3)  ·  Tinnitus (3)  ·  Epilepsy (2)  ·  Headache Disorders, Secondary (2)  ·  Recurrence (2)  ·  Agnosia (1)  ·  Altitude Sickness (1)  ·  Brain Concussion (1)  ·  Brain Diseases (1)

Broader conditions

Central Nervous System Diseases (165)  ·  Nervous System Diseases (165)  ·  Brain Diseases (164)  ·  Headache Disorders, Primary (164)  ·  Headache Disorders (162)  ·  Pathological Conditions, Signs and Symptoms (49)  ·  Neurologic Manifestations (42)  ·  Signs and Symptoms (42)  ·  Pain (30)  ·  Pathologic Processes (12)  ·  Disease Attributes (10)  ·  Otorhinolaryngologic Diseases (7)  ·  Ear Diseases (6)  ·  Cardiovascular Diseases (4)

Interventions

erenumab (20)  ·  Topiramate (16)  ·  Sumatriptan (12)  ·  Metoclopramide (10)  ·  rimegepant sulfate (10)  ·  Botulinum Toxins, Type A (8)  ·  Saline Solution (8)  ·  Bupivacaine (7)  ·  Naproxen (7)  ·  Propranolol (6)  ·  Sodium Chloride (6)  ·  sumatriptan-naproxen (6)  ·  Acetaminophen (5)  ·  Amitriptyline (5)  ·  Diphenhydramine (5)

Sponsors

Montefiore Medical Center (9)  ·  Amgen (6)  ·  Cady, Roger, M.D. (5)  ·  Pfizer (5)  ·  Danish Headache Center (4)  ·  Mayo Clinic (4)  ·  Allergan (3)  ·  Clinvest (3)  ·  Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta (3)  ·  H. Lundbeck A/S (3)  ·  Novartis Pharmaceuticals (3)  ·  Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (3)  ·  Theranica (3)  ·  Thomas Jefferson University (3)  ·  University of California, Irvine (3)

Countries

United States (95)  ·  Italy (14)  ·  Denmark (9)  ·  France (9)  ·  Germany (9)  ·  Spain (9)  ·  Turkey (Türkiye) (9)  ·  Poland (8)  ·  Canada (7)  ·  United Kingdom (7)  ·  Australia (6)  ·  Finland (6)  ·  Austria (5)  ·  China (5)  ·  Czechia (4)

Top investigators

Roger K Cady, MD (8)  ·  Alit Stark-Inbar, PhD (3)  ·  Benjamin W Friedman, MD, MS (3)  ·  Messoud Ashina, MD (3)  ·  Dawn Marcus, MD (2)  ·  Messoud Ashina, Prof. (2)  ·  Ortho McNeil Neurologics, Inc. Clinical Trial (2)  ·  Abeer Salamah, ass prof (1)  ·  Alain Viguier, PH (1)

Results publications

PMID 37303034, PMID 11914403, PMID 12807523, PMID 40275185, PMID 8984084, PMID 11535479, PMID 12598264, PMID 12764341, PMID 14633551, PMID 15107371, PMID 15985582, PMID 16324164, PMID 16492233, PMID 17105455, PMID 17157685, PMID 17300358, PMID 17445101, PMID 17501849, PMID 17504651, PMID 17955107, PMID 18006188, PMID 18156535, PMID 18384420, PMID 18387702, PMID 18534808, PMID 18549410, PMID 18958996, PMID 19486178, PMID 19817885, PMID 20045576, PMID 20236340, PMID 20396496, PMID 20880898, PMID 20974598, PMID 21592098, PMID 21812775, PMID 21880111, PMID 21942531, PMID 22460943, PMID 23567060, PMID 23936605, PMID 24020994, PMID 24030685, PMID 24127709, PMID 24180163, PMID 25323219, PMID 25338927, PMID 25366551, PMID 25415168, PMID 25505035

NIH funding

2019 (5), 2018 (3), 2017 (1), R01DK100368 (1), UL1TR000135 (1)